The Patient-centered HIV Care Model (PCHCM) integrated community-based pharmacists with medical providers and required sharing of patient clinical information and collaborative therapy-related action planning. We determined the proportions of participants with HIV and mental health conditions who were retained in care and the proportion virally suppressed, pre- and post-implementation. Overall, we found a relative 13% improvement in both retention [60% to 68% (p = 0.009)] and viral suppression [79% to 90% (p < 0.001)]. Notable improvements were seen among persons triply diagnosed with HIV, mental illness and substance use [+ 36% (50% to 68%, p = 0.036) and + 32% (66% to 86%, p = 0.001) in retention and viral suppression, respectively]. There were no differences in the proportions of persons adherent to psychiatric medications, pre- to post-implementation, nor were there differences in the proportions of persons retained in care or virally suppressed by psychiatric medication adherence, post-implementation. PCHCM demonstrated that collaborations between community-based pharmacists and medical providers can improve HIV care continuum outcomes among persons with mental health conditions.

以患者为中心的 HIV 护理模式 (PCHCM) 将基于社区的药剂师与医疗提供者整合在一起，并需要共享患者临床信息和与合作治疗相关的行动计划。我们确定了感染艾滋病毒和精神健康问题的参与者在护理中的比例，以及实施前和实施后病毒抑制的比例。总体而言，我们发现保留率 [60% 至 68% (p = 0.009)] 和病毒抑制 [79% 至 90% (p < 0.001)] 均相对提高了 13%。在三重诊断为 HIV、精神疾病和物质滥用的人群中，保留率和病毒性 [+ 36%（50% 至 68%，p = 0.036）和 + 32%（66% 至 86%，p = 0.001）抑制，分别]。坚持服用精神科药物的人的比例没有差异，实施前和实施后，在实施后继续接受治疗或因坚持精神科药物而受到病毒抑制的人数比例也没有差异。PCHCM 表明，社区药剂师和医疗提供者之间的合作可以改善精神健康患者的 HIV 护理连续性结果。